AB Dynamics makes the robots, targets and simulators used to test advanced driver-assistance and autonomous-driving systems. Its underlying margins remained resilient in the first half, but lower Revenue and a £16.8m charge related to its Chinese testing Business produced a substantial statutory loss.
AB Dynamics (LSE:ABDP) has spent more than a decade building a specialist position in automotive testing and simulation. Its products range from driving robots and ADAS targets to advanced simulators and automated vehicle-testing systems.
The long-term Investment case rests on rising testing requirements as vehicles become more automated, software-dependent and subject to increasingly demanding safety protocols. Its first-half 2026 results, however, exposed the business model’s shorter-term risks: order timing can create substantial revenue swings, while a poorly performing Chinese testing contract led to a significant Impairment and strategic review.
The original claim that AB Dynamics held £41.7m of net cash is not supported by its latest published results. The company reported £39.3m of net cash at 28 February 2026, compared with £41.4m at the August 2025 year-end. That remains a strong financial position, but the distinction matters.
What the Company Does
AB Dynamics is based in Bradford-on-Avon, England, and its shares trade on the London Stock Exchange’s AIM market under the ticker LSE:ABDP
The company designs and manufactures systems used by vehicle manufacturers, suppliers, regulators and independent testing organisations to assess vehicle dynamics, durability and safety. Its products increasingly support the development and validation of advanced driver-assistance systems, or ADAS, and autonomous vehicles.
The group reports through three segments.
Testing Products, its largest division, includes steering and pedal robots, ADAS test platforms, soft crash targets and laboratory-testing equipment.
Testing Services conducts outsourced vehicle testing. Its operations include US-based track testing and mileage-accumulation services, as well as the VadoTech on-road testing business in China.
Simulation includes the Ansible Motion driving-simulator operation and associated simulation software. These systems allow manufacturers and development teams to test vehicle behaviour and driver responses in controlled virtual environments.
AB Dynamics’ competitive position rests on specialist engineering expertise, long-standing customer relationships and an established global product base. It supplies more than 150 customers and is largely agnostic about vehicle manufacturer, powertrain and geography.
Why the Stock Is in Focus
AB Dynamics published its interim results for the six months ended 28 February 2026 on 14 April.
Revenue fell 16% to £48.8m from £58.0m. Management said the reduction reflected previously disclosed delays in the timing of orders and deliveries following weaker order intake during the second half of 2025, when Tariff uncertainty affected customer decisions.
Adjusted operating profit also declined 16%, to £9.1m from £10.8m. Despite the lower revenue, the adjusted operating Margin remained unchanged at 18.6%, supported by operational improvements, discretionary cost control and a favourable revenue mix.
The statutory result was considerably weaker because AB Dynamics recognised £16.8m of adjustments related to VadoTech. These comprised a £12.3m impairment of assets, a £4.1m onerous-contract provision and £0.4m of restructuring costs.
Management began a strategic review of VadoTech after the reporting period. The company had not formally announced an exit at the time of the interim results, so describing a Withdrawal from China as decided would go beyond its disclosure.
Importantly, the review concerns VadoTech’s Chinese testing-services operation. Management said it does not affect AB Dynamics’ sales of Testing Products to domestic Chinese manufacturers.
Latest Financial Picture
First-half revenue declined 16% to £48.8m. On a constant-currency basis, the decline was approximately 14%.
Gross margin improved by 350 basis points to 63.7% from 60.2%. Adjusted EBITDA fell 12% to £11.3m, while adjusted operating profit declined 16% to £9.1m.
The adjusted Operating Margin remained at 18.6%. Adjusted Diluted Earnings per Share fell 15% to 31.3p from 37.0p.
After amortisation, acquisition-related expenses, management-transition costs and the VadoTech charges, AB Dynamics recorded a statutory loss before tax of £12.4m. Statutory diluted earnings per share were negative 53.0p.
The distinction between adjusted and statutory performance is significant. Most of the VadoTech adjustment was non-cash, but the impairment represents a loss of value associated with an acquired business and should not be dismissed as merely an accounting technicality.
Cash generation remained solid on the company’s preferred measure. AB Dynamics reported 102% cash conversion for the rolling 12-month period, compared with 98% a year earlier. First-half adjusted Operating Cash Flow was £6.5m, down from £9.3m.
Net cash was £39.3m at 28 February 2026, compared with £41.4m at the August 2025 year-end and £27.2m a year earlier. Gross cash and cash equivalents were £42.9m. The difference means that calling the company completely “debt-free” is less precise than saying it had a substantial net cash position.
The group also had access to a £20m revolving Credit Facility running to February 2029, with an option to extend it for another year.
The Interim Dividend increased 10% to 3.08p per share.
Segment Performance
Testing Products revenue fell 17% to £31.0m. The previous-year period benefited from a substantial delivery of robots to a North American vehicle manufacturer that did not recur.
Segment adjusted operating profit declined 16% to £6.8m, but the adjusted operating margin increased to 21.9% from 21.6%. Management described order intake as encouraging, particularly in Asia-Pacific and North America.
Testing Services revenue fell 29% to £6.5m. Adjusted operating profit declined 37% to £1.2m, reducing the margin to 18.5% from 20.9%.
The headline segment numbers conceal a large difference between VadoTech and the US testing businesses. Excluding VadoTech, Testing Services generated £4.3m of revenue and £1.6m of adjusted operating profit, implying a margin of 37.2%. Management reported strong growth at the US operations.
VadoTech suffered substantially weaker-than-expected volumes under a renewed contract with a European vehicle manufacturer. The customer’s anticipated increase in the number of test vehicles did not materialise amid difficult conditions in China. Management also said Chinese on-road testing services were becoming increasingly commoditised.
Simulation revenue was broadly stable at £11.3m, compared with £11.4m. Adjusted operating profit increased 11% to £3.1m, while its margin rose to 27.4% from 24.6%.
Lower motion-platform sales were offset by higher software revenue. Management expected simulator revenue to be more heavily weighted toward the second half and assumed two further simulator orders in its full-year expectations.
Orders and Full-Year Expectations
First-half order intake was £64m, compared with £66m a year earlier and £110m for the whole of 2025. Management said customer activity had become more positive after a subdued third quarter of 2025.
The closing order book increased 12% to £47m from £42m. Of that amount, £18m was scheduled for delivery in the 2027 financial year.
The £47m order book alone did not represent 70% coverage of expected full-year revenue. Rather, revenue already recognised during the first half plus the portion of the order book scheduled for delivery in 2026 provided approximately 70% coverage.
Management expected 55–60% of full-year revenue to be generated during the second half. Subject to there being no prolonged geopolitical disruption, it continued to expect adjusted operating profit for 2026 to meet market expectations.
At the time of the results, company-compiled analyst consensus was £24.4m of adjusted operating profit and 79.9p of adjusted diluted earnings per share.
The Bull Case
The bull case is that the deterioration was largely about timing and one underperforming acquired operation rather than weakening Demand across the group.
Order intake recovered to £64m, while the order book increased to £47m. Testing Products maintained its margin despite lower sales, and Simulation expanded both profit and margin.
The company remains exposed to attractive structural trends. More vehicle models, increasingly complex ADAS systems, tougher consumer-safety tests and the expansion of automated-driving functions all require additional physical and virtual validation.
New Euro NCAP protocols and the broader adoption of Level 2 driver-assistance systems should increase the range and complexity of testing. Autonomous vehicles also require extensive simulation, track testing and, eventually, independent verification.
AB Dynamics’ £39.3m net cash position and £20m revolving credit facility give it considerable financial flexibility. Management can invest in product development, pursue acquisitions and continue paying dividends without relying heavily on external funding.
The stronger performance of the US Testing Services businesses also suggests that VadoTech’s problems are not representative of the entire services division.
Management continues to target approximately 10% organic revenue growth and an adjusted operating margin above 20% over the medium term. If order conversion improves and the VadoTech drag is removed, those targets leave scope for meaningful earnings growth.
The Bear Case
The bear case begins with the 16% revenue decline. Although delayed orders can eventually convert into sales, the first-half result illustrates how exposed AB Dynamics remains to the timing of large customer projects.
The full-year forecast also depends on a substantial second-half acceleration. With 55–60% of annual revenue expected in the second half, Manufacturing execution, customer acceptance and delivery schedules all become more important.
The VadoTech charge raises legitimate questions about Capital allocation. AB Dynamics acquired the business in 2023, yet less than three years later it recognised impairments and provisions totalling £16.8m and placed the operation under strategic review.
The £12.3m asset impairment is non-cash in the current period, but it reflects value that the company previously paid for and no longer expects to recover. The £4.1m onerous-contract provision also points to continuing costs associated with an unprofitable customer agreement.
Management has not yet disclosed the outcome of the VadoTech review. A restructuring, sale or closure could entail further costs, while retaining the operation could prolong the earnings drag.
Finally, AB Dynamics has historically commanded a premium valuation because of its growth, margins and specialist market position. A company priced for dependable execution can experience a disproportionate de-rating when revenue declines or acquisitions disappoint.
What Could Move the Stock Next?
The most immediate company-specific catalyst will be the outcome of the VadoTech strategic review, which management expected to conclude during the second half of the 2026 financial year.
Investors should watch whether the review results in a sale, restructuring or closure; how much cash the process requires; and whether further impairments or provisions are necessary.
The next trading update and full-year results for the year ending 31 August 2026 will show whether the expected second-half weighting materialised. The company had not provided a firm full-year results date in the materials reviewed, so it is safer not to assign one until formally confirmed.
Order conversion will be critical. Investors should compare the year-end outcome with the £24.4m adjusted operating-profit consensus cited by the company in April.
Further indicators include Testing Products demand in Asia-Pacific and North America, simulator order conversion, software growth and new products designed for the 2026 Euro NCAP testing protocols.
Acquisitions could also move the shares. Management described its pipeline as healthy and said it had sufficient resources to pursue strategically attractive transactions. Following the VadoTech impairment, however, investors are likely to scrutinise future deals more closely.
Outlook
Could autonomous-vehicle testing power the next re-rating in LSE:ABDP shares? The structural opportunity is credible. Vehicles are becoming more automated and software-driven, while testing protocols are growing more complex. AB Dynamics supplies highly specialised products and services needed to validate those systems.
Its underlying first-half performance was also more resilient than the statutory loss implies. Gross margin improved, the adjusted operating margin held at 18.6%, Simulation increased profit and the order book grew.
Nevertheless, the risks are real. Revenue fell materially, the full-year result depends on a strong second half, and the VadoTech impairment represents a significant Acquisition failure. The strategic review remains unresolved.
The Balance Sheet is an important strength, but the correct latest figure is £39.3m of net cash—not £41.7m. A re-rating will probably require more than a strong cash balance. AB Dynamics must convert its order book, deliver the anticipated second-half recovery and resolve VadoTech without another major financial surprise.
The long-term ADAS and autonomous-testing thesis remains intact. Whether it translates into a higher valuation now depends on execution.






Please wait processing your request...